FASN Inhibitor TVB-2640

Known as: TVB-2640 
An orally bioavailable fatty acid synthase (FASN) inhibitor, with potential antineoplastic activity. Upon administration, TVB-2640 binds to and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
01220142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cisplatin-resistant A549CisR and H157CisR cell lines were developed by treating parental A549 (A549P) and H157 (H157P) cells… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2015
Review
2015
Therapies that target tumor metabolism represent a new horizon in anticancer therapies. In particular, cancer cells are dependent… (More)
Is this relevant?
2015
2015
Therapies that target tumor metabolism represent a new horizon in anticancer therapies. In particular, cancer cells are dependent… (More)
  • figure 1
Is this relevant?
2014
2014
Fatty acid synthase (FASN) is the biosynthetic enzyme responsible for the endogenous synthesis of fatty acids. It is… (More)
Is this relevant?
2014
2014
Fatty acid synthase (FASN) is the biosynthetic enzyme responsible for the endogenous synthesis of fatty acids. It is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?